Trial Search Results

Lamotrigine in the Treatment of Bipolar Disorder in Women of Reproductive Age

This project will expand current knowledge of reproductive biology in women with bipolar disorder as well as assessing the impact of lamotrigine use for the treatment of bipolar disorder on reproductive function. Specifically, this study examines mood over the menstrual cycle and ovulation for three consecutive menstrual cycles in women treated for bipolar I, II, or NOS (not otherwise specified) with lamotrigine. In addition, testosterone and lipid concentrations will be measured before the participant starts receiving lamotrigine, as well as six months after receiving lamotrigine.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University

Stanford Investigator(s):

Eligibility


Inclusion Criteria::

   - Female

   - Ages 18 through 45

   - Diagnosis of bipolar disorder (I, II, or NOS)

   - Willing to sign the Human Subject Protection Consent Form prior to enrollment into the
   study

   - Willing to use lamotrigine

   - Never used lamotrigine prior to study entry Exclusion Criteria:- Unwilling or unable
   to comply with study requirements, e.g. complete forms, or attend scheduled
   evaluations

   - Significant alcohol and/or substance abuse or dependence within the prior 6 months

   - Used lamotrigine prior to study entry, or currently using lamotrigine at study entry

Ages Eligible for Study

18 Years - 45 Years

Genders Eligible for Study

Female

Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Not Recruiting